Skip to Content
Merck
CN

263222

Thulium

powder, ~40 mesh, 99.9% trace metals basis

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
Tm
CAS Number:
7440-30-4
Molecular Weight:
168.93
UNSPSC Code:
12352300
PubChem Substance ID:
24855957
EC Number:
231-140-2
MDL number:
MFCD00011281

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

mp

1545 °C (lit.)

InChI key

FRNOGLGSGLTDKL-UHFFFAOYSA-N

InChI

1S/Tm

SMILES string

[Tm]

assay

99.9% trace metals basis

form

powder

reaction suitability

reagent type: catalyst
core: thulium

resistivity

90 μΩ-cm, 20°C

particle size

~40 mesh

bp

1950 °C (lit.)

density

9.332 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

pictograms

FlameExclamation mark
GHS02,GHS07

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Flam. Sol. 1 - STOT SE 3

target_organs

Respiratory system

Storage Class

4.1B - Flammable solid hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
06815AJ
10320BN
04610EF
02330LB
00301LF

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Fabrizio Iacono et al.
BMC surgery, 12 Suppl 1, S21-S21 (2012-11-28)
Over the past years laser technology has played a predominant role in prostate surgery, for the treatment of benign prostate hypertrophy (BPH). Various laser devices have been introduced in clinical practice, showing good results in terms of complications and urodynamic
Burcu Tunc et al.
Lasers in surgery and medicine, 45(1), 48-56 (2013-01-17)
The thermal damage of the surrounding tissue can be an unwanted result of continuous-wave laser irradiations. In order to propose an effective alternative to conventional surgical techniques, photothermal damage must be taken under control by a detailed dose study. Real-time
Richard L Blackmon et al.
Journal of biomedical optics, 18(2), 28001-28001 (2013-02-05)
Fiber-optic attraction of urinary stones during laser lithotripsy may be exploited to manipulate stone fragments inside the urinary tract without mechanical grasping tools, saving the urologist time and space in the ureteroscope working channel. We compare thulium fiber laser (TFL)
Zhonghua Yang et al.
Urology, 81(2), 396-400 (2013-02-05)
To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) and plasmakinetic bipolar resection of the prostate (PKRP) for treating benign prostatic hyperplasia (BPH) in a prospective randomized trial with 18 months of follow-up. The study
Western Bolanos et al.
Optics letters, 37(19), 4032-4034 (2012-10-03)
Continuous wave laser operation at 1.87 μm of liquid-phase epitaxially (LPE) grown Tm(3+)-doped YLiF(4) (Tm:YLF) layers is demonstrated. The waveguide laser delivers 560 mW by pumping with a Ti:Sapphire laser at 780 nm leading to an efficiency of 76% with
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service